Ben-Bassat I - Search Results

1

Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine.

Raanani P, Shpilberg O, Gillis S, Avigdor A, Hardan I, Berkowicz M, Sofer O, Lossos I, Chetrit A, Ben-Yehuda D, Ben-Bassat I. Raanani P, et al. Leuk Res. 1999 Aug;23(8):695-700. doi: 10.1016/s0145-2126(99)00078-8. Leuk Res. 1999. PMID: 10456666

2

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia.

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I. Shpilberg O, et al. Leuk Lymphoma. 1995 Sep;19(1-2):141-4. doi: 10.3109/10428199509059668. Leuk Lymphoma. 1995. PMID: 8574160 Clinical Trial.

3

Postremission therapy with two different dose regimens of cytarabine in adults with acute myelogenous leukemia.

Shpilberg O, Haddad N, Sofer O, Raanani P, Berkowicz M, Chetrit A, Carter A, Ramot B, Tatarski I, Ben-Bassat I. Shpilberg O, et al. Leuk Res. 1995 Dec;19(12):893-7. doi: 10.1016/0145-2126(95)00082-8. Leuk Res. 1995. PMID: 8632657

4

The MACOP-B and VACOP-B combination chemotherapy for young patients with intermediate-grade non-Hodgkin's lymphoma.

Dreiher J, Shpilberg O, Raanani P, Chetrit A, Ben-Bassat I. Dreiher J, et al. Leuk Res. 1998 Nov;22(11):997-1002. doi: 10.1016/s0145-2126(98)00106-4. Leuk Res. 1998. PMID: 9783801 Clinical Trial.

5

Therapy with thalidomide in refractory multiple myeloma patients - the revival of an old drug.

Kneller A, Raanani P, Hardan I, Avigdor A, Levi I, Berkowicz M, Ben-Bassat I. Kneller A, et al. Br J Haematol. 2000 Feb;108(2):391-3. doi: 10.1046/j.1365-2141.2000.01835.x. Br J Haematol. 2000. PMID: 10691870 Free article.

6

Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA--a manifestation of the basic disease or the treatment.

Raanani P, Segal E, Levi I, Bercowicz M, Berkenstat H, Avigdor A, Perel A, Ben-Bassat I. Raanani P, et al. Leuk Lymphoma. 2000 May;37(5-6):605-10. doi: 10.3109/10428190009058513. Leuk Lymphoma. 2000. PMID: 11042521

7

[Treatment of adults with acute lymphoblastic leukemia--results at the Sheba Medical Center, Tel-Hashomer, 1977-1988].

Goldstein G, Shpilberg O, Raanani P, Chetrit A, Ben-Bassat I. Goldstein G, et al. Harefuah. 2000 Oct;139(7-8):255-9, 328, 327. Harefuah. 2000. PMID: 11062964 Hebrew.

8

Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias.

Shimoni A, Kröger N, Zander AR, Rowe JM, Hardan I, Avigdor A, Yeshurun M, Ben-Bassat I, Nagler A. Shimoni A, et al. Leukemia. 2003 Feb;17(2):290-7. doi: 10.1038/sj.leu.2402808. Leukemia. 2003. PMID: 12592325 Clinical Trial.

9

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.

Shimoni A, Kröger N, Zabelina T, Ayuk F, Hardan I, Yeshurun M, Shem-Tov N, Avigdor A, Ben-Bassat I, Zander AR, Nagler A. Shimoni A, et al. Leukemia. 2005 Jan;19(1):7-12. doi: 10.1038/sj.leu.2403591. Leukemia. 2005. PMID: 15526016

10

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity.

Shimoni A, Hardan I, Shem-Tov N, Yeshurun M, Yerushalmi R, Avigdor A, Ben-Bassat I, Nagler A. Shimoni A, et al. Leukemia. 2006 Feb;20(2):322-8. doi: 10.1038/sj.leu.2404037. Leukemia. 2006. PMID: 16307018 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters